Astrazeneca Canada Inc. v. Canada (Minister of Health)

Astrazeneca Canada Inc. v. Canada (Minister of Health)

The Federal Court of Appeal held that the Federal Court applied the correct standard (reasonableness) and that, on the evidence, it was open to the Federal Court to conclude that the Minister acted reasonably in issuing the NOC to Apotex without requiring new patent allegations regarding patents '693 and '891;...

Source-derived case information.

Citation
2005 FCA 58
Parties
Appellant: AstraZeneca Canada Inc.; Respondent: The Minister of Health; The Attorney General of Canada; Respondent: Apotex Inc.
Court
Federal Court of Appeal
Jurisdiction
Canada
Judgment Date
9 February 2005
Procedural Posture
Judicial Review of Administrative Decision (minister of Health Decision to Issue Notice of Compliance) / Appeal to the Federal Court of Appeal From Federal Court Judicial Review Decision
Outcome
Appeal dismissed
Legal Topics
Standard of Review, Notice of Compliance (noc), Patent Allegations, Reasonableness Review
Source Language
en
Administrative Law Patent Law Pharmaceutical Regulation Judicial Review Standard of Review Notice of Compliance (noc) Patent Allegations Reasonableness Review

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Legal principles 2 Authorities cited 4 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Parties

AstraZeneca Canada Inc.

Appellant

The Minister of Health; The Attorney General of Canada

Respondent

Apotex Inc.

Respondent

Procedural Posture

Judicial Review of Administrative Decision (minister of Health Decision to Issue Notice of Compliance) / Appeal to the Federal Court of Appeal From Federal Court Judicial Review Decision

  1. 1 Whether judicial review lay from the Minister's decision to issue a NOC
  2. 2 Whether the Federal Court applied the correct standard of review
  3. 3 Whether the Minister acted reasonably in issuing a NOC to Apotex without requiring new patent allegations regarding patents '693 and '891

Ratio Decidendi

The Federal Court of Appeal held that the Federal Court applied the correct standard (reasonableness) and that, on the evidence, it was open to the Federal Court to conclude that the Minister acted reasonably in issuing the NOC to Apotex without requiring new patent allegations regarding patents '693 and '891; accordingly the appeal is dismissed.

Court Disposition

Appeal dismissed

Orders

  • Appeal dismissed with costs to the Minister of Health and to Apotex Inc.